Albany Molecular Research (AMRI)

2.71 -0.05 -1.81% May 25, 11:00PM Go Pro

Watch this stock

Albany Molecular Research Tangible Book Value: 202.36M

View AMRI Tangible Book Value with YCharts Pro.

Access these YCharts Pro features:

Export any data you want
Save any chart as an image
Utilize advanced screener power
View 30 years of financial history
over 90 advanced calculations
Enjoy an advertising free experience

and much more...

AMRI Tangible Book Value Rankings

Overall	54th percentile	2006 of 4385
Sector	80th percentile	99 of 504 in Healthcare
Industry	85th percentile	23 of 159 in Biotechnology

AMRI Tangible Book Value Range, Past 5 Years

Minimum	202.36M	Mar 2012
Maximum	294.60M	Dec 2009
Average	262.17M

About Tangible Book Value

Tangible book value is calculated by subtracting intangible assets from the company's book value.

Tangible book value excludes:
- Goodwill
- Items classified as "Intangible Assets" on the balance sheet
Learn More

You may also be interested in these AMRI related companies

Options

AMRI News

$AMRI filed latest Quarterly Report http://stks.co/3lpW
about 17 days ago by MarketBrief

ALBANY MOLECULAR RESEARCH INC Files SEC form 10-Q, Quarterly Report
May 10, 1:04PM

New Star Analyst Rankings for Albany Molecular Research, Inc.
May 10, 10:44AM

earnings $NFEC $AMRI $AH http://stks.co/3kXB
about 18 days ago by epime7heus

ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
May 09, 1:47PM

Listen to $AMRI Q1 2012 earnings call - live at 10:00 AM, ondemand after - http://stks.co/3k43
about 18 days ago by earningscast

Albany Molecular Research (AMRI) Misses Q1 EPS by 3c
May 09, 8:15AM Street Insider

AMRI Announces First Quarter 2012 Results
May 09, 8:00AM PR Newswire

Q1 2012 Albany Molecular Research Earnings Release - Before Market Open
May 09, 7:07AM

ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and
May 08, 4:38PM

Troy life-jacket company files bankruptcy, lines up buyer
May 07, 11:41AM

AMRI appoints pharmaceutical executive to board
May 07, 11:24AM

William S. Marth Appointed to AMRI's Board of Directors
May 07, 8:00AM PR Newswire

I need all the ones that horizon Alerted recently that im currently stuck in way down $RCON $AMRI $NFC $SINO and more to go up a lot
about 23 days ago by epime7heus

AMRI to Announce First Quarter Results
May 02, 8:22AM PR Newswire

Consolidation Continues In Mid Cap DX Companies: Bull Market In Biotech Hits New Highs
May 02, 7:02AM

$AMRI resting @ hod rewdy to do a lot more
about 26 days ago by epime7heus

AMRI Launches SMARTSOURCING™ For Contract Manufacturing and Research Services
Apr 30, 8:00AM PR Newswire

D’Ambra’s AMRI compensation up to $4.2 million
Apr 27, 2:00PM

AMRI Hires Director of In Vitro Biology in Singapore
Apr 26, 8:00AM PR Newswire

AMRI Strengthens Business Development and Marketing Groups
Apr 24, 8:00AM PR Newswire

$AMRI looks ready to splode!
about 37 days ago by hoppinjohn

$AMRI anyone????
about 39 days ago by hoppinjohn

AMRI Announces Development and Manufacturing Deal with Biota Holdings Limited
Apr 17, 8:00AM PR Newswire

ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Materi
Apr 12, 4:47PM

ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and
Apr 05, 4:30PM

AMRI (AMRI) Enters Licensing, Development Agreements for ALB 109564
Apr 03, 8:03AM Street Insider

AMRI Signs Exclusive Option to License its Tubulin Inhibitor Program for Cancer
Apr 03, 8:01AM Benzinga

AMRI CFO to Present at 11th Annual Needham Healthcare Conference
Mar 28, 8:00AM PR Newswire

AMRI Hires Senior Manager to Oversee Facilities at Burlington Aseptic Fill Operations
Mar 27, 8:00AM PR Newswire

UPDATE 1-Albany Molecular to close Hungary unit, cut 100 jobs
Mar 21, 5:27PM

Albany Molecular (AMRI) to Cease Operations in Budapest
Mar 21, 5:21PM Street Insider

ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities
Mar 21, 5:02PM

$AMRI filed latest Annual Report http://stks.co/2t5L
about 73 days ago by MarketBrief

ALBANY MOLECULAR RESEARCH INC Files SEC form 10-K, Annual Report
Mar 15, 4:20PM

AMRI Expands Quality Control Leadership to Support Future Growth
Feb 29, 8:00AM PR Newswire

@missyaubaby / what are your thoughts on $AMRI
about 101 days ago by jlangford2

5 Biotech Stocks Undervalued By EPS Trends
Feb 13, 3:21AM

ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
Feb 07, 5:03PM

AMRI reports net loss of $32M in 2011
Feb 07, 12:08PM

Albany Molecular Research (AMRI) Reports Q4 Loss of $0.19; Guides Contract Revs
Feb 07, 8:05AM Street Insider

AMRI Announces Fourth Quarter and Full Year 2011 Results
Feb 07, 8:00AM PR Newswire

Q4 2011 Albany Molecular Research Inc Earnings Release - Before Market Open
Feb 07, 7:07AM

AMRI CFO to Present at UBS 22nd Annual Global Healthcare Services Conference
Feb 01, 8:00AM PR Newswire

AMRI to Announce Fourth Quarter Results
Jan 31, 8:00AM PR Newswire

Albany Molecular U.K. facility gets MHRA GMP certification
Jan 18, 8:05AM

MHRA Issues GMP Certification to AMRI UK Facility
Jan 18, 8:00AM PR Newswire

AMRI Announces Review of Its Hungary Operation
Jan 09, 8:00AM PR Newswire

AMRI Announces Preferred Provider Agreement with BioPontis Alliance LLC
Jan 05, 8:00AM PR Newswire

Stocks to watch Friday: Shutterfly, Rambus, CIT
Dec 23, 6:50AM

UPDATE 1-Albany Molecular cuts jobs in Q4
Dec 22, 5:39PM

InPlay: AMRI announced actions taken in Q4 of 2011 to reduce the co's workforce, right size capacity, and reduce operating costs in 2012
Dec 22, 5:15PM

AMRI Announces Additional Actions to Streamline Operations
Dec 22, 5:15PM Business Wire

Albany Molecular (AMRI) Announces Workforce Reduction, to Cease Facility Lease; Updates on Expected Charges
Dec 22, 5:08PM Street Insider

Albany Molecular (AMRI) Files $50M Mixed Shelf
Dec 22, 5:06PM Street Insider

ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Regulation FD Di
Dec 22, 4:58PM

Insider Cluster-Buying At $AMRI. 23,900 shares purchased. http://stks.co/1Xse
about 165 days ago by abubnic

Sterne Agee reiterated its “Buy” rating on $AMRI with a price target of $7.00.
about 165 days ago by abubnic

$AMRI insider buying first week of Dec. http://stks.co/1XsW
about 165 days ago by abubnic

ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fi
Dec 05, 4:57PM

Albany Molecular management to meet with Sterne Agee
Nov 28, 2:46PM FlyOnTheWall

$AMRI Crossed daily lows support.
about 187 days ago by TradeIdeasQuant

$AMRI New 52 Week Low - Crossed daily lows support.
about 188 days ago by TradeIdeasQuant

ALBANY MOLECULAR RESEARCH INC Financials
Nov 17, 1:04PM

$AMRI New 52 Week Low - Crossed daily lows support.
about 192 days ago by TradeIdeasQuant

$AMRI filed latest Quarterly Report http://stks.co/13cP
about 200 days ago by MarketBrief

sld losing positions in falling knives, including $AMRI, $BWEN, $COCO, $CRU, $FRO, $GMXR, $MYGN, $NOK, $NUVA, $POZN, $RSH, $TBSI, $UNG;
about 278 days ago by txbondman

$AMRI $5.00 Hagen Steven R officer (VP Pharmaceutical Dev & Mfg) S 198 @ $4.84 amnt $958 proc'd ($32) 5/6/2011
about 381 days ago by canarionyc

$AMRI http://chart.ly/xvpba4r Closed above 50 day on high volume, 10% of float is short, MACD looks ready
about 405 days ago by Tr8r_x

$AMRI Hagen Steven R officer (VP Pharmaceutical Dev & Mfg) sold 2,000 @ $5.20 totl $10,400.00 2010-12-06
about 524 days ago by canarionyc

bot $AMRI at 6.44
about 572 days ago by txbondman

start swing long 1k $AMRI on long time coming trend reversal, looking for 6.3 stop 5.3
about 709 days ago by Assailed

Recent Quotes

Symbol	Price	Chg	Chg %	Market Cap
AMRI	2.71	-0.05	-1.81%	83.39M
AMRC	11.07	-0.15	-1.34%	289.15M
AMPL	0.185	+0.01	+2.83%	10.38M
ALVR	0.49	+0.03	+6.52%	28.41M
ALV	57.16	-0.25	-0.44%	5.116B
ALU	1.67	+0.07	+4.38%	3.883B
ALTR	34.42	+0.66	+1.96%	11.11B
ALTI	0.66	+0.00	+0.00%	45.84M
ALTH	1.80	+0.00	+0.00%	192.53M
ALTE	22.72	-0.28	-1.22%	2.292B

Create Watchlist from Stock Quotes